Discover 289 paid clinical trials in Idaho. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Idaho provides a wide range of paid clinical research opportunities for both healthy volunteers and people with specific health conditions. Facilities in Boise, Idaho Falls, and Meridian are actively seeking participants, offering access to new therapies and specialized care.
Filter
1
Filter results
Results: 289
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Sydney, Saint John, Scarborough ME, West Haven CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase3, Recruiting
A Study to Assess Growth in Children With Idiopathic Short Stature
for
Idiopathic Short Stature
Location: Hartford CT, Lebanon NH, Garden City NY, The Bronx NY,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 2 - 16
Code: NCT06309979
Recruiting
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
Location: New York NY, Philadelphia PA, Cleveland OH,
Sponsor: Rapport Therapeutics Inc.
Sex: All
Age: 18 - 70
Code: NCT07219407
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
for
Primary Generalized Tonic-Clonic Seizures
Location: Chestnut Hill MA, Hackensack NJ, Montreal,
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All
Age: 12+
Code: NCT05667142
Phase3, Recruiting
Registry of Deep Brain Stimulation With the VERCISEâ„¢ System: Vercise DBS Registry
for
Parkinson's Disease
Location: Great Neck NY, Miami FL, Williamsville NY,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT02071134
Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Boston MA, Lebanon NH, Stony Brook NY, Long Branch NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase2, Recruiting
The Use of a Dynamic Compression Intramedullary Nail for Tibiotalocalcaneal Arthrodesis
for
Ankle Arthritis, Foot Arthritis
Location: Boise ID
Sponsor: MedShape, Inc
Sex: All
Age: 18+
Code: NCT03686241
Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT06368817
Phase2, Recruiting
EASi-KIDNEYâ„¢ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
for
Kidney Disease, Chronic
Location: Halifax, Portsmouth NH, East Providence RI, Quebec,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06531824
Phase3, Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
for
Asthma
Location: South Dartmouth MA, Boston MA, Jersey City NJ,
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: New Haven CT, Lake Success NY, The Bronx NY,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06545955
Phase3, Recruiting
An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection
for
Clostridium Difficile (C. Difficile)
Location: Saint Johns, San Antonio TX, Butte MT, Idaho Falls ID,